NLRP3 and myocardial infarction: INF4E, a newly synthesized small-molecule inhibitor of NLRP3 inflammasome, significantly reduces myocardial infarct size and LDH release and attenuates the formation of NLRP3 inflammasome in a time-dependent manner [109].